Fierce JPM Week 2025 - Virtual | Questex | 21 January 2025 | Virtual

Connecting minds, igniting change, navigating the future of biopharma and healthcare. A pivotal election, new regulations, and an array of technological advancements are poised to usher in a year marked by innovation and change for biopharma and healthcare.

From thought-provoking discussions on the ever-evolving deal dynamics within the industry to unique insights on the regulatory landscape, treatment breakthroughs, and the strategic deployment of AI, some of the greatest minds in pharma and healthcare will convene to explore the most pressing issues and exciting opportunities on the horizon.

Features:
• Networking: See who's attending, connect & schedule a 1:1 meeting in our Meeting Zone
• Agenda: Bookmark your sessions and create your own personal agenda
• AI Matchmaking: Reach out, connect, & book meetings with like-minded attendees through the app.
• Partners: Learn more about the event’s incredible sponsors
• Announcements: Stay informed with live announcements at the event content

2025 Speakers

KEYNOTE:

Dr. Jill Biden
First Lady of the United States

SPEAKERS:

Hesham Abdullah
Senior Vice President, Global Head Oncology, Research & Development, GSK

Noubar Afeyan
Founder and CEO, Flagship Pioneering; Co-Founder and Board Chairman, Moderna

Nelson Ambrogio
President of Radiology, Bayer Pharmaceuticals

Christopher Arendt, Ph.D.
Chief Scientific Officer, Head of Research, Takeda

Zoey Becker
Staff Writer, Fierce Pharma

Teresa Bitetti
President of the Global Oncology Business Unit, Takeda

Ginny Blocki
Senior Vice President, Global Marketing & Product Management, embecta

Victor Bulto
President, US, Novartis

Stephanie Butler
Senior Conference Production Director, Fierce Life Sciences

Thomas Clozel, MD
Co-Founder & CEO, Owkin

Jon Congleton
CEO, Mineralys Therapeutics

Kevin Conroy
Chairman and CEO, Exact Sciences

Bassil I. Dahiyat, Ph.D.
President & Chief Executive Officer, Xencor

Ebony Dashiell-Aje, PhD
Executive Director & Head of Patient Centered Outcomes Science, BioMarin

Rachel Ellingson
Senior Vice President, Chief Administrative Officer, Zimmer Biomet

Jeffrey Finer, MD, PhD
Chief Executive Officer and Co-Founder, Septerna

Kevin Forrest, Ph.D.
Co-Founder and former CEO, Kate Therapeutics

Christine (Chris) Fox
Executive Vice President, U.S. Commercial, Teva Pharmaceuticals

Jorge S. Reis-Filho, MD, PhD, FRCPath
VP Cancer Biomarker Development, Early Oncology, AstraZeneca

Emmanuel Frenehard
Executive Vice President, Chief Digital Officer, Sanofi

Alexandra Goncalves
VP & Head of Digital Health, Bristol Myers Squibb

Greg Graves
Senior Partner, McKinsey & Company

Anis Ha
SVP, Deputy General Counsel Transactions and Contracting, Eli Lilly and Company

Conor Hale
Senior Editor, FierceMedTech

Janet Hammond, MD, PhD
Chief Development Officer, Atea Pharmaceuticals

Jeffrey Helterbrand, Ph.D.
SVP, Data Sciences, Roche

Quita Highsmith
Vice President and Chief Diversity Officer, Genentech

Eric A. Hughes, MD, PhD
Executive Vice President of Global R&D, Chief Medical Officer, Teva Pharmaceuticals

Troy Ignelzi
CFO, Rapport Therapeutics

Darren Incorvaia
Staff Writer, Fierce Biotech

Lars Fogh Iversen, PhD
Senior Vice President, Digital Science & Innovation, Novo Nordisk A/S

Bahija Jallal, PhD
CEO, Immunocore

Sai Jasti
Head of Data Science & Artificial Intelligence, Bayer Pharmaceuticals R&D

Phil Johnson
Chief Commercial Officer, Evidation Health

Fraiser Kansteiner
Staff Writer, Fierce Pharma

Maha Katabi
General Partner, Sofinnova Investments

Ariel Katz
CEO and Co-Founder, H1

Jeb Keiper
CEO & President, Nimbus Therapeutics, LLC

Najat Khan, PhD
Chief R&D Officer and Chief Commercial Officer, Recursion

Angus Liu
Deputy Editor, Fierce Pharma

Dr. Nadir Mahmood
President, Nkarta

Gabrielle Masson
Associate Editor, Fierce Biotech

Greg Meyers
Executive Vice President, Chief Digital & Technology Officer, BMS

Brian Montgomery
Chief Strategy Officer, GE HealthCare

Raj More
Chief Architect & CEO, RxLogix Corporation

John Murray
VP Global Business Development & Country Head UK, SanaClis

Arif Nathoo
CEO and Co-Founder, Komodo Health

Judith Ng-Cashin, M.D.
Chief Medical Officer, Novotech

Keiko Oishi
President & COO, CMIC HOLDINGS Co., Ltd.

Adam Pearson
Chief Strategy Officer, Astellas

Cindy Perettie
Executive Vice President, Kite, a Gilead Company

Dr. Maria Luisa Pineda
CEO and Co-Founder, Envisagenics

Irfan Qureshi
Chief Medical Officer, Biohaven, Ltd

Mike Riley
CEO, Veranova

Sean Salmon
Executive Vice President and President for the Cardiovascular Business, Medtronic

Puja Sapra
Senior Vice President, Biologics Engineering and Oncology Targeted Delivery, AstraZeneca

David Shrier
Co-Founder & CEO, Phorum.AI

Jorge Santos da Silva
CEO and Co-Founder, MoonLake Immunotherapeutic

Shehnaaz Suliman, M.D., MBA, M.Phil.
Chief Executive Officer, ReCode Therapeutics

Chirag D. Surti
Executive Director, Morgan Stanley

Ramita Tandon
Chief BioPharma Services Officer, Walgreens

Tolga Tanguler
Executive Vice President and Chief Commercial Officer, Alnylam

Arda Ural, PhD
Americas Life Sciences Leader, Ernst & Young LLP

Rebecca Willumson
SVP & Publisher, Fierce Life Sciences and Healthcare

Robert Zirkelbach
Chief Public Affairs Officer & Head of Strategic Initiatives, PhRMA

Mai-Britt Zocca, Ph.D.
Founder and Chief Executive Officer, IO Biotech

2025 Sponsors

• Caryhealth
• Maat